Evidence map›Paper›PMID 39855601›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2025

Large language model-augmented learning for auto-delineation of treatment targets in head-and-neck cancer radiotherapy.

Praveenbalaji Rajendran, Yong Yang, Thomas R Niedermayr, Michael Gensheimer, Beth Beadle, Quynh-Thu Le, Lei Xing, Xianjin Dai

Abstract read
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Clinical Applications of Multimodal Artificial Intelligence in Otolaryngology: A State-of-the-Art Review.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Praveenbalaji RajendranDepartment of Radiation Oncology, Stanford University, Stanford, CA, United States.
Yong YangDepartment of Radiation Oncology, Stanford University, Stanford, CA, United States.
Thomas R NiedermayrDepartment of Radiation Oncology, Stanford University, Stanford, CA, United States.
Michael GensheimerDepartment of Radiation Oncology, Stanford University, Stanford, CA, United States.
Beth BeadleDepartment of Radiation Oncology, Stanford University, Stanford, CA, United States.
Quynh-Thu LeDepartment of Radiation Oncology, Stanford University, Stanford, CA, United States.
Lei XingDepartment of Radiation Oncology, Stanford University, Stanford, CA, United States.
Xianjin DaiDepartment of Radiation Oncology, Stanford University, Stanford, CA, United States. Electronic address: xjdai@stanford.edu.

Funding

Dual Modality X-ray Luminescence CT for in vivo Cancer ImagingR01CA227713 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2019 to 2023
$2.9M
Radioluminescence dosimetry solution for precision radiation therapyR01CA223667 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2018 to 2022
$2.4M
DASSIM-RT and Compressed Sensing-Based Inverse PlanningR01CA176553 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2014 to 2018
$2.4M
Leveraging deep learning for markerless motion management in radiation therapyR01CA256890 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2021 to 2025
$2.1M
NCI NIH HHS R01 CA176553NCI NIH HHS R01 CA223667NCI NIH HHS R01 CA227713NCI NIH HHS R01 CA256890
6 · The paper itself

Abstract

background and purposeRadiation therapy (RT) is highly effective, but its success depends on accurate, manual target delineation, which is time-consuming, labor-intensive, and prone to variability. Despite AI advancements in auto-contouring normal tissues, accurate RT target volume delineation remains challenging. This study presents Radformer, a novel visual language model that integrates text-rich clinical data with medical imaging for accurate automated RT target volume delineation. MATERIALS AND

methodsWe developed Radformer, an innovative network that utilizes a hierarchical vision transformer as its backbone and integrates large language models (LLMs) to extract and embed clinical data in text-rich form. The model features a novel visual language attention module (VLAM) to combine visual and linguistic features, enabling language-aware visual encoding (LAVE). The Radformer was evaluated on a dataset of 2985 patients with head-and-neck cancer who underwent RT. Quantitative evaluations were performed utilizing metrics such as the Dice similarity coefficient (DSC), intersection over union (IOU), and 95th percentile Hausdorff distance (HD95).

resultsThe Radformer demonstrated superior performance in segmenting RT target volumes compared to state-of-the-art models. On the head-and-neck cancer dataset, Radformer achieved a mean DSC of 0.76 ± 0.09 versus 0.66 ± 0.09, a mean IOU of 0.69 ± 0.08 versus 0.59 ± 0.07, and a mean HD95 of 7.82 ± 6.87 mm versus 14.28 ± 6.85 mm for gross tumor volume delineation, compared to the baseline 3D-UNETR.

conclusionsThe Radformer model offers a clinically optimal means of RT target auto-delineation by integrating both imaging and clinical data through a visual language model. This approach improves the accuracy of RT target volume delineation, facilitating broader AI-assisted automation in RT treatment planning.

Indexed as

Head and Neck NeoplasmsRadiotherapy Planning, Computer-AssistedHumansLarge Language ModelsAuto-delineationDeep learningImage-guided radiotherapyImage segmentationLarge language modelVision-language model

Identifiers

PMID39855601
PMCPMC11956750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.